InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Lerner Neil. Director active across 1 company, notably Compass Therapeutics, Inc.. Cumulatively, 4 disclosures have been published. Split: 2 buys · 0 sell. Total volume traded: €50k. Activity tracked since 7 April 2025. The latest transaction was filed on 29 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
Lerner Neil is a declarant linked to Compass Therapeutics, Inc., where he serves as Chief Accounting Officer. The file shows 4 filings in total, and across the 4 sampled filings the buy amount is EUR 50281 and the sell amount is EUR 0, with filings from 2025-04-08 to 2026-04-30; the modal transaction nature is Acquisition.